Rackoff WR - Search Results

1

Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.

Rackoff WR, Orazi A, Robinson CA, Cooper RJ, Alter BP, Freedman MH, Harris RE, Williams DA. Rackoff WR, et al. Blood. 1996 Sep 1;88(5):1588-93. Blood. 1996. PMID: 8781414 Free article. Clinical Trial.

2

Predicting the risk of bacteremia in childen with fever and neutropenia.

Rackoff WR, Gonin R, Robinson C, Kreissman SG, Breitfeld PB. Rackoff WR, et al. J Clin Oncol. 1996 Mar;14(3):919-24. doi: 10.1200/JCO.1996.14.3.919. J Clin Oncol. 1996. PMID: 8622040

3

A case-control retrospective study of the efficacy of granulocyte-colony-stimulating factor in children with neuroblastoma.

Housholder SE, Rackoff WR, Goldman J, Breitfeld PP. Housholder SE, et al. Among authors: rackoff wr. Am J Pediatr Hematol Oncol. 1994 May;16(2):132-7. Am J Pediatr Hematol Oncol. 1994. PMID: 7513135

4

Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy.

Razzouk BI, Hord JD, Hockenberry M, Hinds PS, Feusner J, Williams D, Rackoff WR. Razzouk BI, et al. Among authors: rackoff wr. J Clin Oncol. 2006 Aug 1;24(22):3583-9. doi: 10.1200/JCO.2005.03.4371. J Clin Oncol. 2006. PMID: 16877725 Clinical Trial.

5

High dose cyclophosphamide with carboplatin: a tolerable regimen suitable for dose intensification in children with solid tumors.

Kreissman SG, Rackoff W, Lee M, Breitfeld PP. Kreissman SG, et al. J Pediatr Hematol Oncol. 1997 Jul-Aug;19(4):309-12. doi: 10.1097/00043426-199707000-00008. J Pediatr Hematol Oncol. 1997. PMID: 9256829 Clinical Trial.

6

Pulse oximetry and factors associated with hemoglobin oxygen desaturation in children with sickle cell disease.

Rackoff WR, Kunkel N, Silber JH, Asakura T, Ohene-Frempong K. Rackoff WR, et al. Blood. 1993 Jun 15;81(12):3422-7. Blood. 1993. PMID: 7685205 Free article.

7

Treatment of refractory Evans syndrome with alternate-day cyclosporine and prednisone.

Rackoff WR, Manno CS. Rackoff WR, et al. Am J Pediatr Hematol Oncol. 1994 May;16(2):156-9. Am J Pediatr Hematol Oncol. 1994. PMID: 8166369

8

A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia.

Harousseau JL, Lancet JE, Reiffers J, Lowenberg B, Thomas X, Huguet F, Fenaux P, Zhang S, Rackoff W, De Porre P, Stone R; Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group. Harousseau JL, et al. Blood. 2007 Jun 15;109(12):5151-6. doi: 10.1182/blood-2006-09-046144. Epub 2007 Mar 9. Blood. 2007. PMID: 17351110 Free article. Clinical Trial.

9

Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.

Rackoff WR, Ge J, Sather HN, Cooper HA, Hutchinson RJ, Lange BJ. Rackoff WR, et al. J Pediatr Hematol Oncol. 1999 Jul-Aug;21(4):260-7. doi: 10.1097/00043426-199907000-00005. J Pediatr Hematol Oncol. 1999. PMID: 10445887

10

Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies.

Cortes J, Albitar M, Thomas D, Giles F, Kurzrock R, Thibault A, Rackoff W, Koller C, O'Brien S, Garcia-Manero G, Talpaz M, Kantarjian H. Cortes J, et al. Blood. 2003 Mar 1;101(5):1692-7. doi: 10.1182/blood-2002-07-1973. Epub 2002 Oct 31. Blood. 2003. PMID: 12411300 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters